• Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Home
  • About Us
  • Blog
  • Subscribe to the Journal
  • Contact Us
Sleep Diagnosis and Therapy

Sleep Diagnosis and Therapy

Official Publication of the American Sleep and Breathing Academy

Frost & Sullivan Concludes Time is Ripe for Sleep Market

June 6, 2014 by admin

 

Citing the “large cohort of undiagnosed people with OSA across the globe,” Frost & Sullivan analysts recently identified the sleep world as a “highly attractive market for investments.”

 

The new analysis from Frost & Sullivan’s Technology Breakthroughs in Sleep Apnea finds that the time is ripe for stakeholders to integrate their efforts and develop a standard platform to diagnose and treat sleep apnea patients.

 

“Current treatments for sleep apnea include surgery to correct static obstructions, the use of continuous positive airway pressure (CPAP) devices to supply air, and other devices that help keep the airway open,” said Frost & Sullivan Technical Insights team leader Saju John Mathew. “There are also over 30 different drugs in the market that address OSA issues by increasing the tone of the upper airways and ventilator drive. Other drugs work to reacidify the blood and force the body to breathe more often, balancing the effect of hyperventilation.”

 

According to Frost & Sullivan, a key challenge facing the market is the lack of qualified personnel, such as pulmonologists and otolaryngologists, to diagnose sleep apnea in a timely manner. In addition, poor compliance with CPAP devices – “even though it is safer and more effective than any other surgical therapy – has resulted in sleep apnea and its associated illnesses recurring among patients.”

 

Analysts add that the development of more “ergonomic CPAP devices will help increase patient ability to adhere to sleep therapy. The market is also seeing a rise in newer technologies that replace elaborate practices, target patient comfort to improve compliance, and help drive acceptance of sleep monitoring devices. This includes mandibular repositioning devices, which are cheaper than CPAP devices and more effective than tongue retaining devices; neuromodulators that are being developed with increasingly smaller footprints resulting in small incisions.”

Filed Under: Articles, Blog

Primary Sidebar

More to See

Snoring, American Sleep and Breathing Academy and the NY Times

August 23, 2022 By admin

Jazz Pharma Presents 17 New Posters for SLEEP 2022

June 6, 2022 By admin

Tags

apnea CPAP Health Home Sleep Home Sleep Testing insomnia narcolepsy obstructive sleep apnea Sleep sleep apnea sleep apnea symptoms sleep apnea syndrome sleep apnea treatment sleep appliances sleep buisness Sleep Business sleep center Sleep Centers sleep community sleep diagnosis sleep diagnostic sleep diagnostics sleep disease sleep disorder sleep disorder center sleep disordered breathing sleep disorders sleep heart health sleep industry sleeping Sleep Lab sleep labs sleep management sleep medicine sleep monitor sleep physicians sleep problems sleep studies sleep study sleep technologist sleep test sleep testing Technology therapy Treatment

Footer

About SleepDT

SleepDT Sleep Diagnosis and Therapy is a clinical Journal for allied Sleep Professionals, Neurologists, Psychiatrists, Pulmonologists, Primary Care Physicians, and other medical specialists. We also advocate on behalf of patient care in the field of Sleep Medicine

Recent

  • SUPPORT AND PROMOTE DENTAL SLEEP MEDICINE IN 2023!
  • Snoring, American Sleep and Breathing Academy and the NY Times
  • Jazz Pharma Presents 17 New Posters for SLEEP 2022
  • AJMC Hypes SLEEP 2022
  • Avadel Pharmaceuticals’ Stock Falls

NAVIGATION

  • Home
  • About Us
  • Blog
  • Subscribe to the Journal
  • Contact Us

Copyright © 2023 · Sleep Diagnosis and Therapy